Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NovoCure Ltd Director's Dealing 2024

Jan 11, 2024

31949_dirs_2024-01-11_97138bbd-641a-442f-bb64-c13638ad5935.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2024-01-02

Reporting Person: Leupin Nicolas (N/A)

More from NovoCure Ltd

Proxy Solicitation & Information Statement 2026
May 21
Regulatory Filings 2026
Apr 30
Interim / Quarterly Report 2026
Apr 30
Regulatory Filings 2026
Apr 24
Regulatory Filings 2026
Apr 9
Major Shareholding Notification 2026
Mar 26
Regulatory Filings 2026
Mar 26
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
View all filings →